Filed: 1/15/2025ACC: 0001012975-25-000044
📋 What this filing means
KCK LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $74.96M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$74.96M
Total AUM (reported)
9.67M
Total Shares
Allocation by class
COM$74.91M99.9%
COM NEW$51.4K0.1%
Portfolio Concentration
Top 3$74.96M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.67M
Sole
Full voting authority
9.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
NEUROPACE INC
SOLEShares5.27M
TypeSH
Market value$58.98M
78.69%
Sole
5.27M
Shared
0.00
None
0.00
SIGHT SCIENCES INC
SOLEShares4.37M
TypeSH
Market value$15.92M
21.25%
Sole
4.37M
Shared
0.00
None
0.00
AILERON THERAPEUTICS INC
SOLEShares22.34K
TypeSH
Market value$51.4K
0.07%
Sole
22.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEUROPACE INCSOLE | COM | 5.27M | SH | $58.98M 78.69% | 5.27M | 0.00 | 0.00 |
SIGHT SCIENCES INCSOLE | COM | 4.37M | SH | $15.92M 21.25% | 4.37M | 0.00 | 0.00 |
AILERON THERAPEUTICS INCSOLE | COM NEW | 22.34K | SH | $51.4K 0.07% | 22.34K | 0.00 | 0.00 |